No immediate red flag; monitor for continued selling beyond these amounts or lack of reinvestment. Absence of buy signals, but no material negative catalyst implied.
Price Chart
Executive Summary
Multiple top executives at Vir Biotechnology, including the CEO, CFO, and CMO, sold shares worth over $220K in the past week, following a large block of stock awards totaling over 450,000 shares. The sales appear to be part of a planned divestiture after recent vesting, signaling routine post-award selling rather than a negative outlook.
Key Financial Metrics
Key Facts
- CEO Marianne De Backer sold 19,039 shares for $141,894; also received 285,000 shares via award (likely vesting).
- CFO Jason O'Byrne, CMO Mark Eisner, General Counsel Vanina de Verneuil, and CAO Brent Sabatini each sold between 1,829 and 4,445 shares, totaling $220K in sales over 2 days.
- All five executives received substantial stock awards on 2026-02-22 at $0 price, indicating vesting of prior grants.
- Sales occurred at $7.4528 per share, consistent with market price, suggesting pre-arranged 10b5-1 plans or routine post-vest diversification.
Financial Impact
$220,000 in insider sales; offset by $3.4M in newly vested shares (459,573 shares at $7.45)
Risk Factors
- Perception of lack of confidence if media spins sales negatively.
- Potential for follow-on selling if this is the start of broader divestment.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (10 trades, 7d window) | cluster-VIR-1771978457278 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 7w ago | Court Ruling | $9.24 $9.78 | ▲ +5.84% | ▲ +7.21% | $11.17 (+20.89%) |
Aug 9, 2026 7w ago | Institutional Cluster | $8.89 $9.39 | ▲ +5.62% | ▲ +5.67% | $11.17 (+25.65%) |
Jul 24, 2026 10w ago | 8-K | $8.69 $8.90 | ▲ +2.42% | ▲ +2.04% | $11.17 (+28.54%) |
Jun 29, 2026 13w ago | 144 | $10.38 $10.02 | ▼ −3.47% | ▼ −4.86% | $11.17 (+7.61%) |
Jun 10, 2026 16w ago | 3 | $8.52 $9.30 | ▲ +9.15% | ▲ +8.72% | $11.17 (+31.10%) |
Jun 10, 2026 16w ago | 8-K | $8.52 $9.30 | ▲ +9.15% | ▲ +8.72% | $11.17 (+31.10%) |
Jun 2, 2026 17w ago | Insider Cluster | $8.77 $8.25 | ▼ −5.93% | ▼ −2.11% | $11.17 (+27.37%) |
May 28, 2026 18w ago | 8-K | $9.55 $8.77 | ▼ −8.17% | ▼ −8.12% | $11.17 (+16.96%) |
Apr 16, 2026 24w ago | DEFA14A | $10.33 $10.35 | ▲ +0.19% | ▼ −0.79% | $11.17 (+8.13%) |
Apr 10, 2026 25w ago | 8-K | $9.31 $11.09 | ▲ +19.12% | ▲ +15.82% | $11.17 (+19.98%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access